The WHO Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, in collaboration with the Antimicrobial Resistance Department, is pleased to invite you to a webinar to launch the 2025 Data Report on the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP).
EGASP continues to strengthen national capacity for STI surveillance, epidemiology and gonococcal AMR monitoring and to build technical skills across clinical, epidemiological and laboratory domains. EGASP data are increasingly being used to inform updates to national STI treatment guidelines and to support reviews of national and global recommendations for gonorrhoea testing and treatment.
Taking place during World Antimicrobial Awareness Week (WAAW) 2025, themed “Act Now: Protect Our Present, Secure Our Future,” the launch serves as a call to action to preserve gonococcal surveillance achievements and to build resilience against future antimicrobial threats in STIs.
Date and time
Wednesday, 19 November 2025 | 13:00–14:30 (CET)
Agenda
Time | Session |
| 13:00–13:15 | Introduction and welcome Tereza Kasaeva, Director, Department for HIV, TB, Hepatitis and STIs, WHO Overview of the agenda and objectives Ismail Maatouk, Medical Officer, STIs, Department for HIV, TB, Hepatitis and STIs, WHO |
| 13:15–13:35 | Global updates on emerging AMR in Neisseria gonorrhoeae and launch of new EGASP surveillance report Ismail Maatouk |
| 13:35–13:50 | From the field: Neisseria gonorrhoeae WHO EGASP AMR surveillance
|
| 13:50–14:05 | New gonorrhoea treatments: continuous generation of supporting data Magnus Unemo, WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections, Ӧrebro University, Sweden |
| 14:05–14:15 | How to access new treatments in countries? |
| 14:15–14:25 | Perspectives from the communities Olayinka Fakorede, World Medical Association Junior Doctors Network |
| 14:25–14:30 | Next steps and closing remarks Ismail Maatouk |